Therefore, many ACSS2 inhibitors are needed to be tested in tumor models.281,282 MTB-9655, a kind of small molecule inhibitor of ACSS2, is in phase 1 clinical trial as a potential treatment for patients with cancer (NCT04990739). This evidence concerns the gene ACSS2 and cancer.